Physician

Prince Jit Sidhu, MD

According to 2025 Medicare claims, Prince Sidhu, MD (NPI: 1508816380) practices nephrology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is PARAGON HEALTH, PC (NPI: 1083678767; TIN: 383309299) and primary practice location at 49009-5928.

Sidhu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 329 traditional Medicare patients, billed 956 HCPCS/CPT codes, and received $153,808 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,168 prescription claims across 197 beneficiaries totaling $186,575 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 38 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $244,418 to $186,575. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,812 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	586	1,839	$242,253
2016	550	1,871	$243,048
2017	581	2,057	$247,073
2018	560	1,792	$233,440
2019	519	1,688	$221,458
2020	431	1,418	$195,004
2021	406	1,327	$218,508
2022	369	1,264	$197,038
2023	349	1,182	$177,547
2024	329	956	$153,808

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	197	1,385	$244,418
2016	198	1,350	$279,696
2017	210	1,419	$284,055
2018	203	1,335	$197,655
2019	204	1,176	$192,403
2020	217	1,181	$227,949
2021	221	1,206	$261,051
2022	222	1,085	$184,807
2023	205	1,081	$180,582
2024	197	1,168	$186,575

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	84	$7,148
2016	N/R	126	$10,269
2017	N/R	130	$5,241
2018	N/R	170	$9,961
2019	N/R	157	$8,953
2020	N/R	128	$5,338
2021	N/R	102	$4,670
2022	N/R	79	$3,423
2023	N/R	11	$738
2024	N/R	38	$920

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	44	331	$264
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	49	49	$97
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	35	52	$60
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	155	200	$53
90935	Hemodialysis procedure with physician evaluation	36	62	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	31	1,170	$59,012
Lanthanum Carbonate	Lanthanum Carbonate	30	960	$16,861
Sevelamer Carbonate	Sevelamer Carbonate	109	4,982	$16,740
Potassium Citrate Er	Potassium Citrate	45	3,235	$10,091
Lokelma	Sodium Zirconium Cyclosilicate	23	757	$9,617

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$501
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	12	$257
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Prince Jit Sidhu, MD?

Tedicare shows public-source Medicare data for Prince Jit Sidhu, MD (NPI 1508816380), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Prince Jit Sidhu, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Prince Jit Sidhu, MD?

Prince Jit Sidhu, MD is linked to PARAGON HEALTH, PC (billing NPI 1083678767) in the available physician profile data.

Does Prince Jit Sidhu, MD have Open Payments data?

Prince Jit Sidhu, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.